<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="1" ids="17594">hydroquinone</z:chebi> and <z:chebi fb="5" ids="18135">catechol</z:chebi> like metabolites, NCQ344 and NCQ436 respectively, of the antipsychotic remoxipride have recently been demonstrated to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in myeloperoxidase (MPO)-rich human bone marrow progenitor and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells [S.M </plain></SENT>
<SENT sid="1" pm="."><plain>McGuinness, R </plain></SENT>
<SENT sid="2" pm="."><plain>Johansson, J </plain></SENT>
<SENT sid="3" pm="."><plain>Lundstrom, D </plain></SENT>
<SENT sid="4" pm="."><plain>Ross, Induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by remoxipride metabolites in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 and CD34+/CD19- human bone marrow progenitor cells: potential relevance to remoxipride-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, Chem </plain></SENT>
<SENT sid="5" pm="."><plain>Biol </plain></SENT>
<SENT sid="6" pm="."><plain>Interact </plain></SENT>
<SENT sid="7" pm="."><plain>121 (1999) 253-265] </plain></SENT>
<SENT sid="8" pm="."><plain>In the present study, we determined the molecular mechanisms of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by these remoxipride metabolites in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells </plain></SENT>
<SENT sid="9" pm="."><plain>Our results show that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was accompanied by phosphatidylserine (PS) exposure, activation of caspases-9, -3, -7 and DNA cleavage </plain></SENT>
<SENT sid="10" pm="."><plain>In <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells treated with the <z:chebi fb="1" ids="17594">hydroquinone</z:chebi> NCQ344 and <z:chebi fb="5" ids="18135">catechol</z:chebi> NCQ436, the general caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp. fluoromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi> (Z-VAD.FMK) blocked DNA cleavage and activation of caspases-9, -3/-7 </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, PS exposure was significantly but not completely inhibited by Z-VAD.FMK </plain></SENT>
<SENT sid="12" pm="."><plain>These results demonstrate that although Z-VAD.FMK inhibitable caspases are necessary for maximal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by NCQ344 and NCQ436, additional caspase-independent processes may orchestrate changes leading to PS exposure during <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by the remoxipride polyphenolic metabolites </plain></SENT>
</text></document>